As a result, regulatory approval of new cancer products may speed up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
US NCI contracts push high-risk, high-reward research
Related external links
Rights and permissions
About this article
Cite this article
Alper, J. US NCI launches nanotechnology plan. Nat Biotechnol 22, 1335–1336 (2004). https://doi.org/10.1038/nbt1104-1335
Issue Date:
DOI: https://doi.org/10.1038/nbt1104-1335
This article is cited by
-
Polymeric particle-based therapies for acute inflammatory diseases
Nature Reviews Materials (2022)